Cite
HARVARD Citation
Arbel, Y. et al. (2016). Bezafibrate for the treatment of dyslipidemia in patients with coronary artery disease: 20-year mortality follow-up of the BIP randomized control trial. Cardiovascular diabetology. 15 (1), pp. 1-7. [Online].